Safety and Efficacy of Immune Therapy for Condyloma
NCT03158480
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
80
Enrollment
OTHER
Sponsor class
Conditions
Condylomata Acuminata
Interventions
BIOLOGICAL:
DC-CIK immunotherapy
Sponsor
Shenzhen Second People's Hospital